LONDON–(BUSINESS WIRE)– As Agent Bank, please be advised of the following rate determined on: 1/16/2020 Issue ¦ SBAB Bank AB (publ) Series 668 EUR 1,850,000,000 FRN due January 2021 ISIN Number ¦ XS1347829274 ISIN Reference ¦ 134782927 Issue Nomin EUR ¦ 21000000 Period ¦ 1/20/2020 to 4/20/2020 Payment Date 4/20/2020 Number of…
Details
BOULDER, Colo.–(BUSINESS WIRE)–Global cannabis sales rose 48% to $15 billion in 2019, driven by growth in sales in Canada and seven U.S. states that saw sales more than double. Continued consumer adoption in maturing markets such as Colorado and new adult-use markets including Massachusetts contributed to 45% growth in adult-use sales to $8.9 billion. However,…
Details
TORONTO–(BUSINESS WIRE)–Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce Bophelo Bioscience & Wellness (“Bophelo”) has formally commenced the certification process required to achieve European Good Agricultural and Collection Practices (“EU GACP”) accreditation for cannabis grown at the Company’s 205-hectare cultivation site at Bophelo in Lesotho, Africa.…
Details
PETACH TIKVA, Israel–(BUSINESS WIRE)–Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biopharmaceutical company with a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today announced new findings in its collaboration with Univo Pharmaceuticals (TASE:UNVO) characterizing the effects of cannabinoids on diseases mediated through the A3 adenosine receptor (A3AR). Joint research…
Details
LOS ANGELES–(BUSINESS WIRE)–MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF) plans to release its financial results for the second quarter fiscal 2020 ended December 28, 2019 after market close on Wednesday, February 26, 2020. Following the release of these financial results, at 5:00 PM Eastern that same day, MedMen Enterprises will host…
Details
MONCTON, New Brunswick–(BUSINESS WIRE)–Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce it has secured a supply agreement with Medical Cannabis by Shoppers, the online medical cannabis platform by Shoppers Drug Mart Inc. (“Shoppers”). This agreement reflects…
Details
SAN DIEGO–(BUSINESS WIRE)–Innovative Industrial Properties, Inc. (IIP), the first and only real estate company on the New York Stock Exchange (NYSE: IIPR) focused on the regulated U.S. cannabis industry, announced today that it closed on the acquisition of a property in Richmond, Virginia, which is expected to comprise approximately 82,000 square feet of industrial space…
Details
TORONTO–(BUSINESS WIRE)–Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce Bophelo Bioscience & Wellness (“Bophelo”) has formally commenced the certification process required to achieve European Good Agricultural and Collection Practices (“EU GACP”) accreditation for cannabis grown at the Company’s 205-hectare cultivation site at Bophelo in Lesotho, Africa.…
Details
Yerba Buena is an award-winning Oregon cannabis cultivator of organically-grown flower that offers a consistently clean, effective and delicious experience.
Details
TORONTO–(BUSINESS WIRE)–Morganti & Co., P.C., a cross border shareholder’s rights law firm, has commenced a shareholder class action lawsuit against Auxly Cannabis Group, Inc. (“XLY”) for publishing investor documents containing misrepresentations of material fact about the status of the completion date for the renovations being made to the facility in Cobourg, Ontario (the “Facility”) pursuant…
Details
LOUISVILLE, KY.–(BUSINESS WIRE)–Cornbread Hemp proudly announces they have received organic certification from the National Organic Program of the United States Department of Agriculture (USDA), becoming the first Kentucky CBD company to do so, as reported by WDRB. The USDA organic seal is recognized as a trustworthy guarantee that products bearing it are grown without synthetic…
Details
QUEBEC CITY–(BUSINESS WIRE)–Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv:GSD), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, announced today the signature of a lease Agreement with Hzb Pharma Canada Inc. (Hzb). This agreement includes the installation of state-of-the-art ethanol extraction equipment in Devonian’s…
Details